Theranexus 2023 Investor Presentation

Theranexus is a clinical-stage biotech company developing drug candidates for rare neurological disorders including juvenile Batten disease. The company leverages three scientific platforms—TFEB, neuronal hyperexcitability, and lysosomal diseases—along with innovative numerical methods to identify novel therapies based on pathological disease models.